Aeterna Zentaris to Present at BioContact in Québec City

QUÉBEC CITY, Sept. 26, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: 
AEZS) (TSX:AEZ) (the"Company") today announced that its Senior Vice 
President and CFO, Dennis Turpin, CPA CA, will be presenting a corporate 
overview at BioContact on Wednesday, October 3, 2012, at 2 pm (Eastern), in 
the Grande-Allée Room of the Château Laurier Hotel in Québec City, Canada. 
About Aeterna Zentaris 
Aeterna Zentaris is an oncology and endocrinology drug development company 
currently investigating treatments for various unmet medical needs. The 
Company's pipeline encompasses compounds at all stages of development, from 
drug discovery through to marketed products. For more information please visit 
www.aezsinc.com. 
Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator 
(418) 652-8525 ext. 265 gvallieres@aezsinc.com 
Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. 
406 pburroughs@aezsinc.com 
SOURCE: AETERNA ZENTARIS INC. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/September2012/26/c9570.html 
CO: AETERNA ZENTARIS INC.
ST: Quebec
NI: BTC HEA MTC MED  
-0- Sep/26/2012 11:30 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.